Zentalis Pharma Files SEC Form
Zentalis Pharmaceuticals files DEF 14A with SEC, potentially related to shareholder meeting or corporate action.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.